Abstract: Extracts from Thymus serpyllum L. for use in enteric inflammatory diseases.

Abstract: Cactus pear (Opuntia) extract compositions, their methods of preparation, and their uses in products are provided. The Opuntia extract compositions are a mixture of an extract prepared by extraction of Opuntia fruit/fruit parts, combined with an extract prepared by extraction of Opuntia cladodes/cladode parts. The resulting Opuntia extract compositions exhibit improved therapeutic characteristics as compared with known Opuntia fruit juices or extracts, including increased hypoglycemic effects.

Abstract: Composition comprising an anti-inflammatory plant extract from rosehips together with a cartilage-protective substance, and a method of producing the rosehip extract.

Abstract: Calcium pyruvate and derivatives or formulations thereof can be employed for supporting gut health and lessen inflammations, for example in chronic inflammatory diseases of the digestive tract, and irritable bowel syndrome. Therefore, the invention relates to the use of Calcium pyruvate preparations for treating inflammatory diseases, especially of the digestive tract of humans and mammalian animals, pets and livestock. The digestive tract includes the oral cavity, the pharynx, the esophagus, and the gastrointestinal tract. In one embodiment, said inflammatory disease is an irritable bowel syndrome (IBS) or an inflammatory bowel disease (IBD). In another embodiment, the inflammatory diseases are selected from the group of gingivitis, parodontitis, pharyngitis, esophagitis, gastritis, lymphocytic colitis, ulcerative colitis, diverticulitis, duodenitis, and Crohn's disease.

Abstract: Extracts from Thymus serpyllum L. for use in enteric inflammatory diseases.

Abstract: An extract obtainable by a method comprising the steps extracting Russian Tarragon with water or a mixture of water with up to 20% by volume of a C1 to C3 alcohol.

Abstract: An extract obtainable by a method comprising the steps extracting Russian Tarragon with water or a mixture of water with up to 20% by volume of a C1 to C3 alcohol.

Abstract: Composition comprising an anti-inflammatory plant extract from rosehips together with a cartilage-protective substance, and a method of producing the rosehip extract.

Abstract: A product comprising a) Russian Tarragon (Artemisia dracunculus), an extract of Russian Tarragon or a derivative thereof b) a creatine and/or carnitine compound or derivative or precursor thereof.

Abstract: A process for the preparation of an opuntia extract formulation, comprising the steps of: a) extracting plant parts selected from fruit, fruit parts, and mixtures thereof using an extractant containing water and from 0 to 70% by weight of alcohols; at least partially removing the extractant; b) extracting plant parts selected from cladodes, cladode parts and mixtures thereof using an extractant containing water and from 0 to 70% by weight of alcohols; at least partially removing the extractant; c) mixing together the extracts of step a) and b).

Abstract: A description is given of formulations comprising solid and stable creatine/citric acid composition(s) and carbohydrate(s) or hydrates thereof having a weight ratio of the constituents creatine/citric acid composition(s) and carbohydrate(s) of 1:0.01 to 1.0. Carbohydrate components, which can be used in anhydrous form, as hydrates or as moist products, are in principle all polyhydroxyaldehydes and polyhydroxyketones. The creatine component is preferably used in anhydrous form or in aqueous alcoholic or organic solution. The formulations should preferably be prepared by reacting the carbohydrates in the form of solutions, suspensions or as solid substance with the creatine/citric acid composition or solution thereof at ?20 to 120° C. and, if appropriate, finally removing the liquid phase, or else by a thermal treatment, a treatment with ultrasound or microwave of mixtures consisting of the creatine component and solid carbohydrates, preferably in a vacuum.

Abstract: The invention relates to choline pyruvate of formula (I) wherein 0<n≦10, and is a stabile, physiologically compatible formulation containing said choline pyruvate, water and/or an organic solvent such as glycerine, or is present in a solid and preferably a powder form. The invention also relates to a method for producing choline pyruvate, whereby choline hydroxide is placed in a solvent, such as water or a methanol/water mixture, at a temperature of between 0 and 98° C., then pyruvric acid is added drop by drop in external cooling conditions and mixed until a pH value of between 5.0 and 8.0 is reached, the solvent is then removed and finally the obtained product is added to a physiologically compatible solvent.

Abstract: A new composition for effecting serum cholesterol levels is claimed, said composition comprising a) at least a waxy acid with 23 to 50 carbon atoms or derivatives thereof and with serum cholesterol level reducing properties, and b) 0 to 99.99% by weight of at least a component with serum cholesterol level effecting properties, and c) 0 to 20% by weight of at least a pharmaceutically acceptable formulation aid. The efficacy of this composition can be enhanced by further incorporation of other cholesterol reducing agents, like lecithin, tocotrienol, saponins, fibers, long-chain waxy alcohols and niacin. The claimed composition combines the benefits of the single physiolocology active constituence together with the technology to increase the biovailability.

Abstract: The invention relates to the use of creatine and/or creatine derivatives for treating typical disorders in women, for example PMS or dysmenorrhea, which involves the prophylactic of therapeutic use, in particular, of creatine monohydrate, creatine pyruvates, creatine ascorbates and creatine &agr;-ketoglutarates as creatine derivatives in preferred daily doses of 0.1 g to 20 g. The invention also provides for the use of creatine or its derivatives as mixtures with a pyruvate, ascorbate or &agr;-ketoglutarate. The creatine or its appropriate derivatives are not restricted to any particular form of application, which makes them all the more suitable for the many symptoms of typical female disorders.

Abstract: The invention relates to the use of creatine and/or creatine derivatives for treating typical disorders in women, for example PMS or dysmenorrhea, which involves the prophylactic of therapeutic use, in particular, of creatine monohydrate, creatine pyruvates, creatine ascorbates and creatine &agr;-ketoglutarates as creatine derivatives in preferred daily doses of 0.1 g to 20 g. The invention also provides for the use of creatine or its derivatives as mixtures with a pyruvate, ascorbate or &agr;-ketoglutarate. The creatine or its appropriate derivatives are not restricted to any particular form of application, which makes them all the more suitable for the many symptoms of typical female disorders.

Abstract: A method of producing calcium pyruvates is described, in which calcium salts of organic acids or acidic organic keto or hydroxy compounds are reacted with pyruvic acid at a temperature in the range from −20 to +120° C., if necessary in the presence of a solvent or diluent. In this way, high-purity calcium pyruvates are obtained which can be largely free of water and have a very long shelf life.

Abstract: Water-soluble zinc pyruvates and hydrates thereof of the formula I where x=1.8 to 2.2 and n=0 to 5 are described. The inventive zinc pyruvates are distinguished by a high purity and excellent storage stability and thermal stability and can be employed especially for use as therapeutic agent for treating diabetes, cold prophylaxis, virus inhibition, cytoprotection, as microbicide and as radical absorber and as food supplement or supplement for the prophylaxis and prevention of zinc deficiency symptoms.

Abstract: A method for producing alkali metal and alkaline earth metal pyruvates is disclosed, in which salts of organic acids or acidic organic keto or hydroxy compounds containing as cation one from the group comprising Li, Na, K, Rb, Cs, Mg, Sr and Ba, or mixtures of these salts, are reacted with pyruvic acid at a temperature ranging from −20 to +120°C., if necessary in the presence of a solvent or diluent. In this way, alkali metal and alkaline earth metal pyruvates of high purity are obtained, which can be largely anhydrous and have a very long shelf life. In addition, novel Rb, Cs, Sr and Ba pyruvates are disclosed. These pyruvates are used, for example, to enhance endurance and strength in the field of sport, as protective substances for body cells and tissues, and as food supplements. They are also used for technical applications.

Abstract: Creatine pyruvates are described which have the general formula (I) (creatine)x(pyruvate)y(H2O)n  (I) where x=1 to 100 y=1 to 10 and n=0 to 10 These creatine pyruvates, which are produced by way of the relatively simple reaction of creatine with pyruvic acid, can be used to enhance long-term performance and strength in the field of sport, to reduce weight and body fat in the field of health, to treat conditions of oxygen deficit (ischemia), obesity and overweight, as food supplements and radical scavenger.

Abstract: Creatine pyruvates are described which have the general formula (I)(creatine).sub.x (pyruvate).sub.y (H.sub.2 O).sub.n (I)wherex=1 to 100y=1 to 10 andn=0 to 10These creatine pyruvates, which are produced by way of the relatively simple reaction of creatine with pyruvic acid, can be used to enhance long-term performance and strength in the field of sport, to reduce weight and body fat in the field of health, to treat conditions of oxygen deficit (ischemia), obesity and overweight, as food supplements and radical scavenger.